Nutranomics, Inc. (NNRX)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jan 6, 2026
Nutranomics Market Cap
Nutranomics has a market cap or net worth of $16.75 thousand as of January 21, 2026. Its market cap has decreased by -98.97% in one year.
Market Cap
16.75K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
0.20
Stock Price
$0.00
Market Cap Chart
Since September 20, 2013, Nutranomics's market cap has decreased from 34.88M to 16.75K, a decrease of -99.95%. That is a compound annual growth rate of -46.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 16.75K | - |
| Dec 29, 2025 | 16.75K | - |
| Dec 31, 2024 | 16.75K | - |
| Dec 29, 2023 | 16.75K | -98.97% |
| Dec 30, 2022 | 1.63M | -29.86% |
| Dec 31, 2021 | 2.33M | 41.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |